Abstract:Background: Since its discovery, poly (ADP-ribose) polymerase 1 (PARP-1) has been extensively studied due to its regulatory role in numerous biologically crucial pathways. PARP inhibitors have opened new therapeutic avenues for cancer patients and have gained approval as standalone treatments for certain types of cancer. With continued advancements in the research of PARP inhibitors, we can fully realize their potential as therapeutic targets for various diseases. Purpose: To assess the current understanding of PARP-1 mechanisms in radioprotection and radiotherapy based on the literature. Methods: We searched the PubMed database and summarized information on PARP inhibitors, the interaction of PARP-1 with DNA, and the relationships between PARP-1 and p53/ROS, NF-κB/DNA-PK, and caspase3/AIF, respectively. Results: The enzyme PARP-1 plays a crucial role in repairing DNA damage and modifying proteins. Cells exposed to radiation can experience DNA damage, such as single-, intra-, or inter-strand damage. This damage, associated with replication fork stagnation, triggers DNA repair mechanisms, including those involving PARP-1. The activity of PARP-1 increases 500-fold on DNA binding. Studies on PARP-1-knockdown mice have shown that the protein regulates the response to radiation. A lack of PARP-1 also increases the organism's sensitivity to radiation injury. PARP-1 has been found positively or negatively regulate the expression of specific genes through its modulation of key transcription factors and other molecules, including NF-κB, p53, Caspase 3, reactive oxygen species (ROS), and apoptosis-inducing factor (AIF). Conclusion: This review provides a comprehensive analysis of the physiological and pathological roles of PARP-1 and examines the impact of PARP-1 inhibitors under conditions of ionizing radiation exposure. The review also emphasizes the challenges and opportunities for developing PARP-1 inhibitors to improve the clinical outcomes of ionizing radiation damage.

The dynamics and Regulation of PARP1 and PARP2 in response to DNA damage and during replication

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities

PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair.

Functions of Poly(adp-Ribose) Polymerase (PARP) in DNA Repair, Genomic Integrity and Cell Death

Molecular Pathways: Targeting PARP in Cancer Treatment

Advances and Perspectives of PARP Inhibitors

XRCC1 mediates PARP1- and PAR-dependent recruitment of PARP2 to DNA damage sites

PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention

Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis

Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics

PARP Mediated DNA Damage Response, Genomic Stability and Immune Responses

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways

The role of PARP1 in the DNA damage response and its application in tumor therapy

Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases

Modulatory Potential of Poly (ADP‐Ribose) Polymerase 1 (PARP1) in BRCA‐Mutated Tumors

PARP1: Liaison of Chromatin Remodeling and Transcription

PARP inhibitors for anticancer therapy

Functional Aspects of PARP1 in DNA Repair and Transcription

DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy